Search Results for "Rationale Of The Drug Sensorcaine"
Original Source: Sensorcaine-MPF Spinal Injection [APP Pharmaceuticals, LLC]
Matching Channels
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in e...
Drug Discovery - news, views, blogs and reports
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. In the past most drugs have been discovered either by identi...
Matching News
New rationale for treating patients with cirrhosis and portal hypertension
New data from clinical studies presented for the first time at the International Liver Congress- 2013 provide new rationale for an old and established treatment option for portal hypertension.
The rationale for targeting the LOX family in cancer
The family of lysyl oxidases (LOX) seem to have dichotomous roles in tumour progression: suppressing tumorigenesis and promoting metastasis. This Review discusses the functions of the LOX family and t...
Drug companies, universities unite in new drug development
Drug companies are partnering with universities to develop drugs, and are even recruiting academic scientists. -More- New Apoptosis-Targeting Drug Gets B Cells, Spares Platelets Researchers...
Targeting MET in cancer: rationale and progress
New concepts in the design of drug-eluting coronary stents
New-generation drug-eluting stents (DES) utilize various drugs, polymers, and scaffold technologies, which have improved the safety of these stents in comparison with first-generation DES. Clinicians...
SILVER SPRING, Md., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology and clinical stage provider of natural products and cell and gene therapy solutions fo...
BMJ publishes papers critical of Novo's postmarketing studies
The British Medical Journal published three articles questioning the rationale for postmarketing observational studies conducted by Novo Nordisk A/S (CSE:NVO, NYSE:NVO) for its new insulin products, a...
Matching PubMed Articles
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling.
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery process to identify undesirable off-target activity profiles that could hinder or halt the development of ca...
The role of impulsivity in the aetiology of drug dependence: reward sensitivity versus automaticity.
RATIONALE: Impulsivity has long been known as a risk factor for drug dependence, but the mechanisms underpinning this association are unclear. Impulsivity may confer hypersensitivity to drug reinforce...
Quantifying the chemical beauty of drugs.
Drug-likeness is a key consideration when selecting compounds during the early stages of drug discovery. However, evaluation of drug-likeness in absolute terms does not reflect adequately the whole sp...
RATIONALE: Relapse is a persistent problem in the management of addiction. Drug-related cues are powerful instigators of relapse. Impulsive decision making may contribute to rela...
Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.
RATIONALE: Most studies on the subjective effects of ecstasy are based on the assumption that the substance that was taken is 3,4-methylenedioxymethamphetamine (MDMA). However, m...
